3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Locally Recurrent Skin Squamous Cell Carcinoma
1
Leukemia, Plasma Cell
1
Endometrial Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Classic Follicular Lymphoma
1
Carcinoma, Renal Cell
1
Interventions
Dexamethasone
4
Cyclophosphamide
4
Bortezomib
3
daratumumab
2
belantamab mafodotin
2
venetoclax
1
pegfilgrastim
1
ixazomib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Lenalidomide
1
Calcium Dobesilate
1
Antineoplastic Protocols
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Amyloidosis
×
Hyaluronoglucosaminidase
×
1 year
×
Clear all
No trials found.